Acquiring Company
Novartis
Acquired Company
Sironax
Switzerland
BeijingBiotechnologyHealth CarepharmaceuticalsBiotechnologyHealth CareTherapeuticsDescription
Sironax announced that Novartis has exercised its option to acquire the full global rights to its proprietary brain delivery platform. This acquisition, following an agreement from July 2025, includes a payment of $125 million. Sironax will retain rights for selected assets using the platform while advancing its clinical programs. This event validates Sironax's technology and R&D capabilities.
Don't miss Novartis's next move
Get an email the moment Novartis makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Sironax?
Sironax was acquired by Novartis, based in Switzerland. The deal was reported on September 16, 2026. Novartis India Ltd is a subsidiary of Novartis AG, focusing on healthcare products for chronic conditions. The company has a diverse portfolio including diabetes, neurology, and cardiology therapies. Novartis is publicly traded (NVS) and operates in Biotechnology.
When did Novartis acquire Sironax?
Novartis's acquisition of Sironax was reported on September 16, 2026. Sironax announced that Novartis has exercised its option to acquire the full global rights to its proprietary brain delivery platform. This acquisition, following an agreement from July 2025, includes a payment of $125 million. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Sironax do?
Sironax is a clinical-stage biotechnology company dedicated to the discovery and global development of novel treatments for patients with age-related degenerative diseases. It is privately held, operating in Biotechnology, and is based in Beijing.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.